(Q74841476)

English

Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine

scientific article published on 01 November 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11672897%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11672897%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

based on heuristic

inferred from title

Loek van Alphen

8

object named as

L van Alphen

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11672897%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

author name string

E de Kleijn

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11672897%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

L van Eijndhoven

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11672897%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

C Vermont

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11672897%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

B Kuipers

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11672897%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

H van Dijken

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11672897%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

H Rümke

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11672897%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

R de Groot

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11672897%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

G van den Dobbelsteen

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11672897%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

language of work or name

0 references

publication date

1 November 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11672897%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11672897%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11672897%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

3-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11672897%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

352-358

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11672897%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900371-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Human IgG subclass pattern of inducing complement-mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900371-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900371-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900371-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific IgG4 responses during chronic and transient antigen exposure in aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900371-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900371-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900371-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900371-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900371-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900371-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900371-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation of Neisseria meningitidis mutants deficient in class 1 (porA) and class 3 (porB) outer membrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900371-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900371-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900371-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900371-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900371-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Laboratory correlates of protection against Haemophilus influenzae type b disease. Importance of assessment of antibody avidity and immunologic memory

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900371-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A/C polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900371-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(01)00371-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11672897%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11672897%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74841476&oldid=1775337471"